Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study.
Cytokine
; 128: 154984, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-31972343
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Interleukin-2
/
Kidney Neoplasms
Type of study:
Prognostic_studies
Language:
En
Journal:
Cytokine
Year:
2020
Type:
Article